Furthermore, GI tumors are highly heterogeneous
Expressed as a percentage, with normal being below 5.7%, prediabetes 5.7-6.4%, and diabetes 6.5% or higher
Whilst not officially listed as a common side effect, our patients taking GLP-1 receptor agonist injections have often reported increased hair loss during treatment
When something isnt quite right, whether its a slow-healing injury or a change in how your horse moves, it can be difficult to know what the next step should be
Here's what an independent audit verified, and why it matters for telehealth patients
Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: retrospective analysis of Japanese individuals with type 2 diabetes